Skip to main content
. 2023 Feb 21;21:18. doi: 10.1186/s12955-023-02097-y

Table 3.

Study design characteristics of the included studies (n = 70)

Study design n (%) Follow-up n (%) Funding n (%) Multicentric n (%) Pilot Study n (%)
RCTs 44 (62.9) Yesa 39 (55.7) Yes 43 (61.4) Yes 17 (24.3) Yes 20 (28.6)
Pre-post Clinical Trial (no control group) 22 (31.4) No 31 (42.3) No 27 (38.6) No 53 (75.7) No 50 (71.4)
Non-RCT 4 (5.7)

aFollow-up range: 1–36 months